Tisotumab Vedotin co-developed by Genmab and Seattle Genetics
ADCs: a more effective, less harmful, targeted approach
Seattle Genetics and Unum enter into strategic cancer immunotherapy collaboration
Seattle Genetics and Genmab enter into new antibody-drug conjugate collaboration
Novel paths to treating rare diseases
Genmab expands collaboration with Seattle Genetics
Genmab and Seattle Genetics enter research collaboration
